Taiwan Biomaterial Co., Ltd.(TW:6649)
NT$35.65-0.25 (-0.70%)
TW:6649
Taiwan Biomaterial Co., Ltd. financials statements
NT$35.65
At close:-0.25 (-0.70%)
Taiwan Biomaterial Co., Ltd. (6649) Income Statement
Taiwan Biomaterial Co., Ltd. Income Statement
Last quarter (Q2 2026), Taiwan Biomaterial Co., Ltd.'s total revenue was NT$36.94M, an increase of 9.34% from the same quarter last year. In Q2, Taiwan Biomaterial Co., Ltd.'s net income was NT$622.00K. See Taiwan Biomaterial Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| NT$ 220.40M | NT$ 96.57M | NT$ 72.84M | NT$ 127.31M | NT$ 41.67M | |
| NT$ 123.10M | NT$ 57.31M | NT$ 47.12M | NT$ 76.09M | NT$ 21.09M | |
| NT$ 62.26M | NT$ 68.54M | NT$ 47.12M | NT$ 50.62M | NT$ 77.80M | |
| Depreciation and Amortization | NT$ 16.64M | NT$ 17.68M | NT$ 17.86M | NT$ 16.90M | NT$ 11.06M |
| NT$ 76.30M | NT$ 15.99M | NT$ 9.71M | NT$ 51.63M | NT$ -35.35M | |
| NT$ 60.83M | NT$ -11.23M | NT$ -14.22M | NT$ 25.46M | NT$ -56.72M | |
| NT$ -1.91M | NT$ 8.74M | NT$ 5.19M | NT$ 8.29M | NT$ 9.28M | |
| NT$ 58.93M | NT$ -2.49M | NT$ -9.03M | NT$ 33.76M | NT$ -47.44M | |
| NT$ 58.93M | NT$ -1.73M | NT$ -10.13M | NT$ 33.76M | NT$ -47.44M | |
| Per Share Metrics | |||||
| Basic EPS | NT$ 1.40 | NT$ -0.04 | NT$ -0.24 | NT$ 0.83 | NT$ -1.44 |
| Diluted EPS | NT$ 1.40 | NT$ -0.04 | NT$ -0.24 | NT$ 0.83 | NT$ -1.44 |
| Weighted Average Shares Outstanding | 42.00M | 42.00M | 42.21M | 40.87M | 33.00M |
| Weighted Average Shares Outstanding (Diluted) | 42.07M | 42.00M | 42.21M | 40.89M | 33.00M |
Currency in TWD
